Stock Events

Stock Events

Search...

BB Biotech

$61.55

266

+$0+0% Tuesday 20:03

Statistics

Day High

33.65

Day Low

33.65

52W High

61.55

52W Low

33.65

Volume

100

Avg. Volume

7

Mkt Cap

0

P/E Ratio

-

Dividend Yield

4.63%

Dividend

2.85

Upcoming

Dividend Payment

Dividend Payment

Dividends

4.63%Dividend Yield

Mar 26

$2.86

Mar 25

$2.04

Mar 24

$2.22

Mar 23

$3.11

Mar 22

$4.12

10Y Growth

19.57%

5Y Growth

-5.48%

3Y Growth

-5.08%

1Y Growth

30.84%

Earnings

21OctExpected

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

-12.83

-1.86

9.1

20.07

Expected EPS

N/A

Actual EPS

-6.6352

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBAGF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Biotechnology ETF, competes by investing in biotech companies, similar to BB Biotech's investment strategy.

State Street SPDR S&P Biotech

SPDR S&P Biotech ETF, competes as it also focuses on biotechnology investments, offering a similar market exposure.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, a direct competitor through its biotech-focused investment portfolio.

ARK Genomic Revolution

ARK Genomic Revolution ETF, competes by investing in the genomic industry, overlapping with BB Biotech's investment interests.

VanEck Vectors Biotech ETF, offers exposure to biotech firms, directly competing with BB Biotech's investment focus.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF, competes by focusing on healthcare innovation, including biotech, similar to BB Biotech.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genomic revolution, akin to BB Biotech's strategy.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, competes by investing in small- and mid-cap biotech companies, a market segment also targeted by BB Biotech.

Direxion Daily S&P Biotech Bull 3X

Direxion Daily S&P Biotech Bull 3X Shares, competes as a leveraged ETF focusing on biotech, offering aggressive exposure similar to BB Biotech's sector focus.

Direxion Daily S&P Biotech Bear 3X

Direxion Daily S&P Biotech Bear 3X Shares, competes by offering inverse exposure to the biotech sector, providing an alternative strategy to BB Biotech's investments.

About

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Show more...

CEO

Employees

10

Country

CH

ISIN

CH0038389992

Listings

0 Comments

Share your thoughts

FAQ

What is BB Biotech stock price today?▼

The current price of BBAGF is $61.55 USD — it has increased by +0% in the past 24 hours. Watch BB Biotech stock price performance more closely on the chart.

What is BB Biotech stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange BB Biotech stocks are traded under the ticker BBAGF.

What were BB Biotech earnings last quarter?▼

BBAGF earnings for the last quarter are 9.11 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.

Does BB Biotech pay dividends?▼

Yes, BBAGF dividends are paid annual. The last dividend per share was 2.86 USD. As of today, Dividend Yield (FWD)% is 4.63%.

How many employees does BB Biotech have?▼

As of April 01, 2026, the company has 10 employees.

When did BB Biotech complete a stock split?▼

The last stock split for BB Biotech was on March 29, 2016 with a ratio of 5:1.